Does Ketamine Therapy Really Work? What the Science Says

If you've been following mental health news in recent years, you've likely encountered headlines about ketamine therapy — once known primarily as an anesthetic and, unfortunately, as a party drug — now being hailed as a breakthrough treatment for depression, PTSD, and chronic pain. But does ketamine therapy really work, or is it just another overhyped wellness trend?

At West Eastern Health in Ponte Vedra Beach, FL — serving patients from Jacksonville and Northeast Florida — we offer ketamine-assisted therapy in a clinically supervised environment. Lauren Marchefka, MSN, PMHNP-BC, FNP-BC, is certified in psychedelic therapy through the California Institute of Integral Studies (CIIS) and the Multidisciplinary Association for Psychedelic Studies (MAPS), bringing evidence-based expertise to this innovative treatment modality.

In this article, we'll examine what the science actually says about ketamine therapy, how it works in the brain, what conditions it treats most effectively, and what you can realistically expect from treatment.

What Is Ketamine Therapy?

Ketamine is a medication that has been used safely in medical settings since the 1970s, primarily as an anesthetic. In recent years, researchers discovered that when administered at lower, sub-anesthetic doses, ketamine produces rapid and significant improvements in mood disorders — particularly treatment-resistant depression.

Ketamine therapy typically involves:

• Intravenous (IV) infusions administered in a clinical setting over 40-60 minutes
• Intramuscular (IM) injections for certain protocols
• Intranasal esketamine (Spravato), the FDA-approved nasal spray form
• Integration therapy — counseling sessions before and after treatment to process the experience

The ketamine-assisted therapy model combines the neurobiological effects of the medication with psychotherapeutic support, maximizing both safety and therapeutic benefit.

Does Ketamine Therapy Get You High?

This is one of the most common questions patients ask — and it's an important one. The honest answer is: ketamine can produce dissociative effects during treatment, but this is not the same as recreational drug use.

During a ketamine infusion, patients may experience:

• A sense of detachment from their body or surroundings (dissociation)
• Altered perception of time
• Visual or auditory distortions
• A feeling of floating or drifting
• Deep relaxation or mild euphoria

These effects are temporary, supervised, and clinically monitored. They typically last only during the infusion and resolve within 1-2 hours. Many clinicians believe these dissociative effects may actually contribute to ketamine's therapeutic mechanism by allowing patients to temporarily step outside entrenched negative thought patterns.

Importantly, ketamine therapy in a medical setting is not about getting high — it's about catalyzing neuroplastic change in the brain to relieve suffering. Patients are closely monitored throughout treatment, vital signs are tracked, and a healthcare provider is present at all times.

How Does Ketamine Work in the Brain?

Unlike traditional antidepressants that target serotonin, norepinephrine, or dopamine systems and can take weeks to work, ketamine acts on the glutamate system — the brain's primary excitatory neurotransmitter. Specifically, ketamine blocks NMDA receptors, which triggers a cascade of neurochemical events:

1. Rapid synaptic growth: Ketamine stimulates the release of brain-derived neurotrophic factor (BDNF), which promotes the formation of new neural connections
2. Increased synaptic plasticity: The brain becomes more capable of forming new pathways and "rewiring" maladaptive circuits
3. Reduced inflammation: Ketamine has been shown to reduce neuroinflammation, which is increasingly recognized as a contributor to depression
4. mTOR pathway activation: This cellular signaling pathway is crucial for neuroplasticity and may explain ketamine's rapid antidepressant effects

Research published in Nature has demonstrated that ketamine can restore synaptic connections in brain regions affected by chronic stress and depression — essentially helping the brain rebuild damaged neural architecture.

What Does the Research Say About Ketamine for Depression?

The evidence for ketamine in treating depression — particularly treatment-resistant depression (TRD) — is compelling.

Clinical Trial Results

A landmark 2000 study published by researchers at Yale University found that a single ketamine infusion produced rapid antidepressant effects within hours in patients with major depressive disorder. Since then, dozens of randomized controlled trials have replicated these findings.

Key research highlights include:

• Response rates of 50-70% in patients with treatment-resistant depression who failed multiple prior antidepressants
• Rapid onset: Significant improvement often occurs within 24 hours, compared to 4-6 weeks for traditional antidepressants
• Reduction in suicidal ideation: Multiple studies have shown ketamine rapidly reduces suicidal thoughts, even in high-risk patients
• Durability: Effects from a single infusion typically last 3-7 days; repeated infusions extend benefits

A 2018 meta-analysis published in the American Journal of Psychiatry reviewed 10 randomized controlled trials and confirmed that ketamine produces large, rapid antidepressant effects compared to placebo.

FDA Approval and Clinical Use

In 2019, the FDA approved esketamine (Spravato) — a nasal spray form of ketamine — specifically for treatment-resistant depression. This marked a significant milestone, as it was the first truly novel antidepressant mechanism approved in decades.

Ketamine for PTSD: What the Evidence Shows

While research on ketamine for PTSD is less extensive than for depression, early results are promising.

Studies suggest ketamine may help with PTSD through several mechanisms:

• Disrupting trauma memory reconsolidation: Ketamine administered during or after trauma memory recall may weaken the emotional intensity of traumatic memories
• Reducing fear conditioning: Animal studies show ketamine can interfere with learned fear responses
• Treating comorbid depression: Many PTSD patients also suffer from depression, and ketamine addresses both conditions

A 2014 study published in JAMA Psychiatry found that a single ketamine infusion significantly reduced PTSD symptoms for up to one week. Subsequent trials have explored repeated dosing protocols and ketamine-assisted psychotherapy models that combine medication with trauma processing.

Organizations like MAPS (Multidisciplinary Association for Psychedelic Studies) are actively researching psychedelic-assisted therapies, including ketamine, for PTSD and other trauma-related conditions.

Ketamine for Chronic Pain: Emerging Applications

Beyond mental health, ketamine shows promise for treating chronic pain conditions, particularly neuropathic pain and complex regional pain syndrome (CRPS).

Research indicates ketamine may help with pain through:

• NMDA receptor antagonism: Blocking pain signal transmission at the spinal cord level
• Central sensitization reduction: Decreasing the nervous system's amplification of pain signals
• Anti-inflammatory effects: Reducing neurogenic inflammation

A 2017 Cochrane Review examining ketamine for chronic pain found moderate-quality evidence supporting short-term pain relief, though long-term efficacy and optimal dosing protocols require further study.

What Can Patients Realistically Expect?

While the research is encouraging, it's important to have realistic expectations about ketamine therapy.

What Ketamine Therapy Is Good For

• Treatment-resistant depression (tried 2+ antidepressants without adequate response)
• Rapid relief of acute suicidal ideation
• PTSD, particularly when combined with trauma-focused therapy
• Certain chronic pain conditions (CRPS, neuropathic pain)
• Providing a "window" of symptom relief that allows engagement in psychotherapy

What Ketamine Therapy Is Not

• A permanent cure — most patients require maintenance infusions
• A replacement for psychotherapy, lifestyle changes, or other treatments
• Appropriate for everyone — contraindications include uncontrolled hypertension, active substance use disorder, certain cardiac conditions, and psychotic disorders
• A quick fix without integration work — therapeutic benefits are maximized when combined with counseling

Typical Treatment Protocol

A standard ketamine protocol for depression often includes:

1. Initial series: 6 infusions over 2-3 weeks
2. Response assessment: Evaluation of symptom improvement
3. Maintenance phase: Booster infusions every 2-6 weeks as needed
4. Integration therapy: Counseling sessions to process insights and consolidate gains

At West Eastern Health, Lauren Marchefka works collaboratively with patients to develop individualized protocols based on their specific needs, medical history, and treatment goals.

Is Ketamine Therapy Safe?

When administered in a supervised medical setting by trained professionals, ketamine therapy has an excellent safety profile.

Common Side Effects

• Transient dissociation during infusion
• Mild nausea
• Elevated blood pressure (monitored throughout treatment)
• Dizziness or lightheadedness immediately after treatment

These effects are typically mild and resolve quickly after the infusion ends.

Long-Term Safety

Concerns about ketamine abuse potential and bladder toxicity (seen in chronic recreational users) do not apply to medically supervised, low-dose therapeutic use. The dosing, frequency, and monitoring protocols used in clinical ketamine therapy are designed to maximize benefits while minimizing risks.

The National Institute of Mental Health (NIMH) continues to fund research on ketamine's long-term safety and efficacy, with ongoing trials examining optimal treatment protocols.

Who Is a Good Candidate for Ketamine Therapy?

You may be a candidate for ketamine therapy if you:

• Have treatment-resistant depression (inadequate response to 2+ antidepressants)
• Experience severe, persistent depressive symptoms that interfere with daily functioning
• Have PTSD symptoms that haven't responded adequately to trauma-focused therapy alone
• Struggle with chronic suicidal ideation
• Have certain chronic pain conditions that haven't responded to conventional treatments
• Are willing to engage in integration therapy and follow-up care

Who Should Not Use Ketamine Therapy

Ketamine may not be appropriate if you have:

• Uncontrolled high blood pressure or heart disease
• Active substance use disorder
• A history of psychotic disorders (schizophrenia, bipolar with psychotic features)
• Certain neurological conditions
• Pregnancy or breastfeeding

A thorough medical and psychiatric evaluation is essential before beginning treatment.

The Bottom Line: Does Ketamine Therapy Really Work?

Based on the current body of research, the answer is yes — ketamine therapy can be highly effective for certain conditions, particularly treatment-resistant depression.

Key takeaways:

• Multiple randomized controlled trials demonstrate ketamine's rapid antidepressant effects
• Response rates of 50-70% in treatment-resistant populations exceed those of traditional antidepressants
• Effects on suicidal ideation can be life-saving
• Emerging evidence supports use for PTSD and chronic pain
• Treatment is safe when administered in a supervised medical setting
• Best results occur when ketamine is combined with psychotherapy and integration work

However, ketamine is not a miracle cure or a replacement for comprehensive mental health care. It's a powerful tool that, when used appropriately and combined with therapeutic support, can provide rapid relief and create a window of opportunity for deeper healing work.

Ketamine Therapy at West Eastern Health

At West Eastern Health in Ponte Vedra Beach, we approach ketamine therapy as part of an integrative mental health model. Lauren Marchefka's training in psychedelic therapy through CIIS and MAPS ensures that treatment is delivered with clinical expertise, trauma-informed care, and a commitment to patient safety.

We offer:

• Comprehensive psychiatric evaluation to determine candidacy
• Individualized treatment protocols tailored to your needs
• Medical monitoring throughout each infusion
• Integration therapy sessions to maximize therapeutic benefit
• Ongoing support and maintenance planning

If you've struggled with treatment-resistant depression, PTSD, or chronic pain and are curious whether ketamine therapy might be right for you, we invite you to schedule a consultation.

Call West Eastern Health at (904) 593-8480 or visit us at 4210 Valley Ridge Blvd, Suite 101, Ponte Vedra Beach, FL 32081. Serving patients throughout Jacksonville and Northeast Florida.

References

1. Berman RM, et al. Antidepressant effects of ketamine in depressed patients. Biological Psychiatry. 2000;47(4):351-354.
2. Zarate CA Jr, et al. A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression. Archives of General Psychiatry. 2006;63(8):856-864.
3. Murrough JW, et al. Rapid and longer-term antidepressant effects of repeated ketamine infusions in treatment-resistant major depression. Biological Psychiatry. 2013;74(4):250-256.
4. Romeo B, et al. Meta-analysis of short- and mid-term efficacy of ketamine in unipolar and bipolar depression. Psychiatry Research. 2015;230(2):682-688.
5. Feder A, et al. Efficacy of intravenous ketamine for treatment of chronic posttraumatic stress disorder. JAMA Psychiatry. 2014;71(6):681-688.
6. Li L, Vlisides PE. Ketamine: 50 Years of Modulating the Mind. Frontiers in Human Neuroscience. 2016;10:612.
7. Corriger A, Pickering G. Ketamine and depression: a narrative review. Drug Design, Development and Therapy. 2019;13:3051-3067.